Bertacchini et al. [39] investigated 80 samples of primary cells from AML patients and found that inhibition of Akt and mTOR resulted in paradoxical activation of growth factor receptor tyrosine kinases (RTKs). The gene discussed is MTOR; the disease is acute myeloid leukemia.